• Users Online: 589
  • Print this page
  • Email this page
DRUG PROFILE
Year : 2019  |  Volume : 10  |  Issue : 4  |  Page : 481-485

Topical ciclopirox olamine 1%: Revisiting a unique antifungal


1 Department of Dermatology and Dermatosurgery, Skinnocence, The Skin Clinic and Research Centre, Gurugram, Haryana, India
2 Department of Dermatology and STD, LHMC and Associated Hospitals, Panchwati-Delhi, India
3 Dermato Venereology (Skin/VD) Center, Sehgal Nursing Home, Panchwati-Delhi, India

Correspondence Address:
Sidharth Sonthalia
Department of Dermatology and Dermatosurgery, Skinnocence: The Skin Clinic and Research Centre, Gurugram - 122 009, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/idoj.IDOJ_29_19

Rights and Permissions

The injudicious use of antifungals, indiscriminate use of corticosteroids for instant relief, persistence of predisposing factors like sweat retention and uncontrolled diabetes, and emerging resistance to antifungals across the globe have rendered the management of an erstwhile simple infection, the superficial cutaneous mycoses highly complicated and tricky. Ciclopirox is an old yet efficacious, versatile, and safe topical antifungal of the hydroxypyridone family. Despite its numerous beneficial properties over the majority of other topical antifungals, it remains underutilized.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed515    
    Printed2    
    Emailed0    
    PDF Downloaded100    
    Comments [Add]    

Recommend this journal